PC
ALXN
Paulson & Co’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,400,000
| Closed | -$214M | – | 44 |
|
|
2021
Q1 | $214M | Buy |
1,400,000
+1,150,000
| +460% | +$176M | 4.92% | 5 |
|
|
2020
Q4 | $39.1M | Buy |
+250,000
| New | +$39.1M | 1.01% | 18 |
|
|
2017
Q3 | – | Sell |
-103,200
| Closed | -$12.6M | – | 98 |
|
|
2017
Q2 | $12.6M | Sell |
103,200
-231,000
| -69% | -$28.1M | 0.17% | 53 |
|
|
2017
Q1 | $40.5M | Buy |
334,200
+180,859
| +118% | +$21.9M | 0.54% | 31 |
|
|
2016
Q4 | $18.8M | Sell |
153,341
-74,359
| -33% | -$9.1M | 0.24% | 43 |
|
|
2016
Q3 | $27.9M | Sell |
227,700
-40,300
| -15% | -$4.94M | 0.3% | 39 |
|
|
2016
Q2 | $31.3M | Buy |
268,000
+110,800
| +70% | +$12.9M | 0.32% | 40 |
|
|
2016
Q1 | $21.9M | Buy |
+157,200
| New | +$21.9M | 0.16% | 48 |
|